# LITHOBID

NDC: 62559-280
Generic name: lithium carbonate
Labeler / Manufacturer: ANI Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20140701

FDA application: NDA018027

## Active ingredients

- LITHIUM CARBONATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62559-280"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62559-280
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7f5b69a-c2a1-4586-a189-1475d41387c0